Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02994693 · ClinicalTrials.gov registry record

Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy

A clinical trial of Barrett Esophagus and Barretts Esophagus With Dysplasia, sponsored by Massachusetts General Hospital.

Active
Registry status
100
Enrollment target
1
Study location

NCT02994693 is a study of Barrett Esophagus and Barretts Esophagus With Dysplasia that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 100 participants, below the 3,562-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02994693, a study of Barrett Esophagus and Barretts Esophagus With Dysplasia, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this research is to determine the natural history of Barrett's esophagus (BE) using tethered capsule endomicroscopy (TCE) in participants undergoing surveillance endoscopy.

Interventions

  • DEVICE OFDI capsule imaging

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2016-12
Est. Completion 2029-12

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT02994693

The ClinicalTrials.gov registry entry for NCT02994693 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,562-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (97% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which OFDI capsule imaging is the first listed.

NCT02994693 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02994693 about?

NCT02994693 is a clinical study titled "Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy". The goal of this research is to determine the natural history of Barrett's esophagus (BE) using tethered capsule endomicroscopy (TCE) in participants undergoing surveillance endoscopy.

What is the current status of trial NCT02994693?

This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2016-12. Estimated completion is 2029-12.

What conditions does trial NCT02994693 study?

This clinical trial studies the following conditions: Barrett Esophagus, Barretts Esophagus With Dysplasia.

What interventions are being tested in trial NCT02994693?

The interventions under investigation include: OFDI capsule imaging (DEVICE).

Who is sponsoring clinical trial NCT02994693?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02994693 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Barrett Esophagus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.